With FDA input pending, the companies are targeting a Phase 3 trial launch in the first half of 2026
[DOI] [PubMed] [Google Scholar] 47.Harada K, Shen WJ, Patel S, Natu V, Wang J, et al
Its well-characterized pharmacological profile has established 5-Amino-1MQ as a valuable research tool for studying NNMT enzyme biology, enzyme-inhibitor interactions, methylation pathway regulation, nicotinamide-associated metabolic networks, and structure-activity relationships involving NNMT-targeting compounds
However, compounded versions are not identical to the original prescription drug, and their consistency can vary
You have the option to come into the office for your injections or to administer them yourself at home if you are comfortable doing so